StimulusBio is Presenting!
On November 7, 2024, StimulusBio’s Chief Executive Officer, Mimi Healy, PhD, joined an esteemed panel of scientific and industry leaders for the session “Boost Your Biotech: Non-Dilutive Funding for Life Science Companies” at the Texas Life Science Forum. The discussion took place in Room 1003 from 1:00 – 2:00 PM.
The panel brought together experts across academia, biotech, and investment strategy to explore how life science companies can leverage non-dilutive funding sources to accelerate innovation without giving up equity.
Joining Dr. Healy on stage were:
- Rebecca Berdeaux, PhD – Chief Scientific Officer, CellChorus
- Elaine Lea-Chou, PhD – Scientific Advisor, Gulf Coast Consortia
- Susan Marriott, PhD – Professor, Baylor College of Medicine; President, BioScience Writers
Dr. Healy shared StimulusBio’s perspective on how grant funding, strategic collaborations, and translational partnerships can empower biotech teams to scale research efficiently, while keeping ownership intact.
This engaging session underscored the importance of creative funding strategies in today’s rapidly evolving life sciences landscape and offered actionable insights for entrepreneurs and researchers alike.
https://txlifescienceforum.org/
StimulusBio is a proud 2024 sponsor!
